Contact Persons:

Funding:

Clinical Research Funding of the University of Oldenburg

Current Status:

Finished.

Early detection and health care of prostate cancer patients

Early detection and health care of prostate cancer patients – a transnational comparison of political impact assessment and empirical evaluation of the regional heterogeneity in medical care

Description:

The Division of Epidemiology and Biometry cooperates with the University Hospital for Urology on a project concerning the care and epidemiology of prostate cancer. This project deals with different topics regarding prostate cancer such as a bi-national small-scale comparison between the Netherlands and Germany and early detection based on the PSA-test.

Country-specific recommendations on PSA-screening are likely to have an impact on different trends such as increasing prostate cancer incidence. This may also be the case for Germany and the Netherlands. In addition, within-country variability of PSA-testing exists, which is rather driven by individual practice patterns of general practicioners than by national guidelines.

This work is conceived as a multi-stage pre-study for an international project and can be divided in three parts: i) assessment of political impact on regional prostate cancer distribution in Lower Saxony and the province of Groningen; ii) pilot survey to evaluate the health care situation of prostate cancer patients; iii) analysis of regional health care network for prostate cancer patients.

Publications:

  • Kappen S, Koops L, Jürgens V, Freitag MH, Blanker MH, Timmer A, de Bock GH.  General practitioners' approaches to prostate-specific antigen testing in the north-east of the Netherlands. BMC Fam Pract. 2020; 21: 270. doi: 10.1186/s12875-020-01350-3
  • Kappen S, Jürgens V, Freitag MH, Winter A. Early detection of prostate cancer using prostate-specific antigen testing: an empirical evaluation among general practitioners and urologists. Cancer Manag Res. 2019; 11: 3079–3097. doi: 10.2147/CMAR.S193325

Selected Conference Papers:

  • Kappen S, Jürgens V, Freitag MH, Winter A. Attitudes and approaches of urologists and general practitioners toward prostate-specific antigen testing in Germany: a cross-sectional survey (Vortrag). DKVF 2020, Berlin; 30.09.20
  • Kappen S, Jürgens V. Leitlinien und Empfehlungen zur Prostatakrebsfrüherkennung mittels
    PSA-Testung – Deutschland und die Niederlande im Vergleich. GMDS 2018, Osnabrück; 02.9. - 05.9.2018
  • Kappen S, Winter A, Wawroschek F, Timmer A, Jürgens V. PSA-Testung als Früherkennungsuntersuchung – eine empirische Evaluation der hausärtzlichen Versorgungsrealitäten in Niedersachsen (Deutschland) und der Provinz Groningen (Niederlande) – GMDS 2017, Oldenburg; 17.9. - 21.9.2017
  • Kappen S, Winter A, Timmer A, Jürgens V. PSA-Testung als Früherkennungsuntersuchung – eine empirische Evaluation der haus- und fachärztlichen Versorgungsheterogenität – QoCC 2017, Berlin
(Changed: 2021-04-30)